PUT - SPRINTER OPEN END - ELI LILLY & CO Stock

Certificat

DE000VD1JH89

Real-time Boerse Frankfurt Warrants 04:11:31 2024-05-22 am EDT
18.02 EUR -0.72% Intraday chart for PUT - SPRINTER OPEN END - ELI LILLY & CO
Current month-13.74%
1 month-29.07%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 18.02 -0.72%
24-05-21 18.15 -11.07%
24-05-20 20.41 -4.00%
24-05-17 21.26 +1.63%
24-05-16 20.92 +2.75%

Real-time Boerse Frankfurt Warrants

Last update May 22, 2024 at 04:11 am EDT

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VD1JH8
ISINDE000VD1JH89
Date issued 2024-03-05
Strike 1,001 $
Maturity Unlimited
Parity 10 : 1
Emission price 19.69
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 26.34
Lowest since issue 17.81
Spread 0.3
Spread %1.63%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
803.2 USD
Average target price
850.4 USD
Spread / Average Target
+5.88%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW